The altered immune cell composition, particularly the reduction in immunosuppressive MDSCs, may paradoxically create a more inflammatory but less tumor-permissive environment, which could explain why GKN2 loss alone was insufficient for tumor development. This evidence concerns the gene GKN2 and neoplasm.